Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies
Journal of the American Society for Mass Spectrometry · 2024
DOI: 10.1021/jasms.3c00342 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2024. Written by Mohammed Rahman and 5 co-authors. Institution: Department of Chemistry, University of Warwick, Coventry, CV4 7AL, U.K. Major MEDLINE topics: Lithium, Silver. Cited 4 times so far (Crossref); 91 references. The full text is freely available (open access, CC BY 4.0). Funded by: AstraZeneca, University of Warwick.
Abstract (original language)
Proteolysis targeting chimeras (PROTACs) are specialized molecules that bind to a target protein and a ubiquitin ligase to facilitate protein degradation. Despite their significance, native PROTACs have not undergone tandem mass spectrometry (MS) analysis. To address this gap, we conducted a pioneering investigation on the fragmentation patterns of two PROTACs in development, dBET1 and VZ185. Employing diverse cations (sodium, lithium, and silver) and multiple tandem-MS techniques, we enhanced their structural characterization. Notably, lithium cations facilitated comprehensive positive-mode coverage for dBET1, while negative polarity mode offered richer insights. Employing de novo structure determination on 2DMS data from degradation studies yielded crucial insights. In the case of VZ185, various charge states were observed, with [M + 2H]2+ revealing fewer moieties than [M + H]+ due to charge-related factors. Augmenting structural details through silver adducts suggested both charge-directed and charge-remote fragmentation. This comprehensive investigation identifies frequently dissociated bonds across multiple fragmentation techniques, pinpointing optimal approaches for elucidating PROTAC structures. The findings contribute to advancing our understanding of PROTACs, pivotal for their continued development as promising therapeutic agents.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, U.K.
- Department of Physics, University of Warwick, Coventry, CV4 7AL, U.K.
- Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, SK10 4TF, U.K.
- New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, SK10 4TF, U.K.
ORCID profiles: Stephen W Holman, Mark Barrow, Andrew D Ray, Peter B O'Connor
Funding
- AstraZeneca
- University of Warwick
Cite
APA
Rahman, M., Marzullo, B., Holman, S. W., Barrow, M., Ray, A. D., & O'Connor, P. B. (2024). Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00342
Vancouver
Rahman M, Marzullo B, Holman SW, Barrow M, Ray AD, O'Connor PB. Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.3c00342
BibTeX
@article{Rahman2024,
author = {Rahman, Mohammed and Marzullo, Bryan and Holman, Stephen W and Barrow, Mark and Ray, Andrew D and O'Connor, Peter B},
title = {Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2024},
doi = {10.1021/jasms.3c00342}
}
EUVIMED